Trial Profile
Evaluation of the effect of metronidazole on the change in perianal Crohn's disease activity.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jun 2010
Price :
$35
*
At a glance
- Drugs Metronidazole (Primary)
- Indications Crohn's disease
- Focus Registrational; Therapeutic Use
- Sponsors SLA Pharma
- 23 Jun 2010 New trial record.